JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ALNY - Alnylam Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary ALNY Stock
Financials
Financials ALNY Stock
Loading...
Loading...
Income Statement
Income Statement ALNY Stock
Balance Sheet
Balance Sheet ALNY Stock
Cash Flow Statement
Cash Flow Statement ALNY Stock
Loading...
Loading...
ALNY Financials - Alnylam Pharmaceuticals Income & Cash Flow | Ledgeburg
Home
Stocks
Alnylam Pharmaceuticals, Inc. (ALNY)
Financials
Financials of ALNY
Loading...
Loading...
Loading...
Loading...
Revenue
$3.713937B
Operating Income
$501.578M
Net Income
$313.747M
Share Count (Basic)
131.004M
Operating Cash Flow
$524.08M
Free Cash Flow
$465.383M
Cash And Short-Term Equivalents
$1.65725B
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
1B
2B
3B
4B
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
500M
1B
Q4 FY24
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-1B
-500M
0
FY2021
Annual
Quarterly
Margins
Gross
Operating
Net
-100%
-50%
0%
50%
100%
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-100M
0
100M
200M
300M
Q4 FY24
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-20%
0%
20%
40%
60%
80%
Q4 FY24
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25